Product Description
Dofetilide is used to treat an irregular heartbeat (including atrial fibrillation or atrial flutter). It is in a class of medications called antiarrhythmics. It improves your heart rhythm by relaxing an overactive heart. (Sourced from: https://medlineplus.gov/druginfo/meds/a601235.html)
Mechanisms of Action: Potassium Channel Blocker
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Bangladesh | Brazil | European Medicines Agency | Germany | Ireland | New Zealand | Portugal | United Kingdom | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|